Animal African trypanosomoses (AAT) are caused by flagellated protozoa of the Trypanosoma genus and contribute to considerable losses in animal production in Africa, Latin America and South East Asia. Trypanosoma congolense is considered the economically most important species. Drug resistant T. congolense strains present a threat to the control of AAT and have triggered research into discovery of novel trypanocides. In vivo assessment of trypanocidal efficacy relies on monitoring of treated animals with microscopic parasite detection methods. Since these methods have poor sensitivity, follow-up for up to 100 days after treatment is recommended to increase the chance of detecting recurrent parasitaemia waves. Molecular techniques are more amendable to high throughput processing and are generally more sensitive than microscopic detection, thus bearing the potential of shortening the 100-day follow up period. The study presents a "Touchdown" PCR targeting the internal transcribed spacer 1 of the ribosomal DNA (ITS1 TD PCR) that enables detection and discrimination of different Trypanosoma taxa in a single run due to variations in PCR product sizes. The assay achieves analytical sensitivity of 10 parasites per ml of blood for detection of T. congolense savannah type and T. brucei, and 100 parasites per ml of blood for detection of T. vivax in infected mouse blood. The ITS1 TD PCR was evaluated on cattle experimentally infected with T. congolense during an investigational new veterinary trypanocide drug efficacy study. ITS1 TD PCR demonstrated comparable performance to microscopy in verifying trypanocide treatment success, in which parasite DNA became undetectable in cured animals within two days post-treatment. ITS1 TD PCR detected parasite recrudescence three days earlier than microscopy and had a higher positivity rate than microscopy (84.85% versus 57.58%) in 66 specimens of relapsing animals collected after treatments. Therefore, ITS1 TD PCR provides a useful tool in assessment of drug efficacy against T. congolense infection in cattle. As the assay bears the potential for detection of mixed infections, it may be applicable for drug efficacy studies and diagnostic discrimination of T. vivax and T. congolense against other pathogenic trypanosomes, including T. brucei, T. evansi and T. equiperdum.
Development and evaluation of an ITS1 "Touchdown" PCR for assessment of drug efficacy against animal African trypanosomosis 
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Introduction
Animal African trypanosomoses (AAT) are infectious diseases of livestock that kill approximately 3 million cattle each year, with a further 50 million at risk of the disease (FAO, 2003) . AAT contribute to poor meat and milk production, poor growth of young stock and reduction in fertility (Shaw et al., 2014) . The causative agents of AAT are flagellated protozoa of the Trypanosoma genus. Trypanosoma congolense, T. vivax and T. brucei cause wasting disease nagana, mainly in ruminants, and are transmitted by tsetse flies in sub-Saharan Africa. T. vivax also occurs in Latin America where it is transmitted by other blood sucking flies. T. evansi causes surra in camels, horses and ruminants and occurs in Northern and Eastern Africa, Latin America, South East Asia and sporadically in Southern Europe. T. equiperdum causes dourine that is a sexually transmitted ubiquitous disease of equines (Hoare, 1972) . T. congolense is considered the economically most important species that induces severe pathology in cattle, including anaemia, weakness and immune depression (Sharpe et al., 1982; Mwangi et al., 1990) . Emergence of drug resistance presents a threat to the control of trypanosomosis and has triggered research on new compounds against African trypanosomes (Chitanga et al., 2011; Mungube et al., 2012) .
The UK government's Department for International Development (DFID) has funded an AAT drug, diagnostics and vaccine discovery programme administered by the Global Alliance for Livestock Veterinary Medicines (GALVmed) a not-for-profit company based in Edinburgh, Scotland. A key effort in this programme is to discover and develop new trypanocide treatments to overcome current issues of toxicity and resistance which are inherent to the existing trypanocides (homidium, isometamidium, and diminazene) that have been used in Africa for more than 50 years. Given the significant resources and effort invested in human African trypanosomosis (HAT) drug discovery by groups such as the Drugs for Neglected Diseases initiative (DNDi) the opportunity exists to explore candidate trypanocidal compounds for efficacy against AAT. GALVmed has defined trypanocide compound progression criteria and Target Product Profile (TPP) criteria for AAT trypanocides to aid in their development and is progressing suitable candidates into development for therapeutic and prophylactic treatments of AAT (http://www.galvmed. org/2012/04/trypanosomosis/). Development includes assessing the efficacy of suitable candidate trypanocide compounds against drug-resistant T. congolense and T. vivax isolates in the target species, namely cattle.
Trypanocide efficacy studies determine parasite clearance in cattle following treatment. These studies are however hampered by the generally low analytical sensitivity of microscopical trypanosome detection methods resulting in a recommended 100 days of post treatment follow-up with frequent examination of the blood (Eisler et al., 2001) . A commonly used microscopic test and considered "gold standard" is the haematocrit centrifugation technique (HCT, (Woo, 1970) ) with a generally accepted detection limit of about 500 parasites per ml of blood. As HCT detects living trypanosomes, the test should be performed quickly after specimen collection. To overcome the limitations of microscopical analysis, molecular methods have been introduced in compound efficacy studies against AAT. For example, a PCR targeting a Trypanosomatidae-specific 18S rDNA was able to detect T. evansi parasites with a median of 10 days earlier than HCT in goats that relapsed more than 100 days after treatment (Gillingwater et al., 2011) . Another PCR, targeting multi-copy internal transcribed spacer 1 (ITS1) rDNA sequences, may serve the same purpose but with the advantage that it is able to identify the trypanosome species or subgenus by the amplicon length polymorphism (McLaughlin et al., 1996) .
ITS1, situated between the conserved 5.8S and 18S genes encoding the ribosomal RNA subunits, occurs in approximately 100-200 copies per genome of a trypanosome. Due to variation in sizes of ITS1 amongst different Trypanosoma taxa, discrimination between species or subgenus is possible in a single run (McLaughlin et al., 1996; Desquesnes et al., 2001 ). ITS1 or nested ITS1/ITS2-based PCR assays have proven useful in trypanosomosis diagnosis and in epidemiological studies (Njiru et al., 2005; Cox et al., 2005; Thumbi et al., 2008; de Clare Bronsvoort et al., 2010; Fikru et al., 2012) . The authors claimed that the universal ITS-based PCR assays reduce cost and time of running several species-specific assays, especially in largescale studies. ITS1 PCR that was used in an epidemiological survey in Ethiopia revealed a five-fold higher detection rate for T. vivax compared to HCT (Fikru et al., 2012) . However, evaluation of the assay as a test of cure has not been reported and these ITS1 PCR assays are prone to non-specific amplification, particularly with bovine blood (unpublished observations). Therefore, the assay presented in this study was further refined for optimal performance. "Touchdown" PCR approach, which employs more stringent primer-template hybridisation temperatures, was introduced to enhance assay specificity. In Touchdown PCR, the annealing temperature during the first PCR cycles is well above the predicted optimal annealing temperature of the primers thus favouring the amplification of the specific target sequence. In the following PCR cycles, the annealing temperature is gradually lowered to more permissive temperatures. By maintaining the same high number of amplification cycles as in a classical PCR, the sensitivity is not compromised (Don et al., 1991; Korbie and Mattick, 2008) .
The objectives of this study were (1) to develop an ITS1 "Touchdown" PCR for multi-taxon detection of the Trypanosoma genus and (2) to evaluate the performance of this ITS1 TD PCR as test of cure in an efficacy study designed to evaluate novel trypanocidal compounds in cattle infected with T. congolense.
Materials and methods

Ethical clearance
Animal studies at the Institute of Tropical Medicine (ITM, Antwerp, Belgium) received ethical clearance from the Veterinary Ethics Committee at ITM (BMW 2012-1 and BMW 2013-7).
Animal studies at ClinVet (Bloemfontein, South Africa) received ethical approval from the ClinVet Animal Ethics Committee (CAEC) authorising the research facility to conduct three studies CV12/884; CV 12/928; CV12/885. Animals were housed and cared for in accordance with national and international legislation, and local animal regulatory requirements.
Parasite strains
The following T. congolense strains were used for infection of cattle: KONT 2/133, KONT 2/151 (Mamoudou et al., 2008) , Maputo 31J, Maputo 02J (unpublished).
For test development, the following strains were used for infection of mice: T. congolense YOBO 2038, TRT 17, Lion 209 , STIB 212 (Nantulya et al., 1980) ; T. vivax ILRAD 700, IL 1392 (Leeflang et al., 1976) ; T. brucei brucei AnTat 1.1, T. b. gambiense AnTat 9.1 (Van Meirvenne et al., 1975) , T. evansi RoTat 1.2 (Bajyana Songa and Hamers, 1988), T. b. rhodesiense ETat 1.2 (Van Meirvenne et al., 1976) , T. equiperdum OVI (Barrowman, 1976) and T. theileri Melsele (Verloo et al., 2000) .
Trypanocide efficacy studies
The trypanocide efficacy studies were carried out at ClinVet, Bloemfontein, South Africa. All cattle were Trypanosoma-susceptible, castrated males and females of the Friesian-Holstein breed. The animals were at least four months of age and had been weaned for at least two months. Animals originated from a tsetse and Trypanosoma-free area, were negative for trypanosomosis (PCR-RFLP assay for T. congolense and T. vivax, (Geysen et al., 2003) ) and negative for T. theileri on blood smear performed at ClinVet International (Pty) Ltd. Animals were identified by ear tags, were weighed at regular intervals throughout the study and were given a standard diet of hay and a commercial, supplemented, concentrate feed (without added antimicrobial agents) sufficient to support growth rates of approximately 700 g/day in healthy growing cattle. Animals were housed in a fully enclosed, purpose-built, fly-proof facility for cattle containing 36 flexible pens.
For this evaluation, blood samples from a total of 57 animals across 3 studies were used. Twelve animals were non-infected and 45 animals were infected with a single T. congolense strain per animal. Fresh heparinised blood (0.1 mL) from an infected donor animal containing the pathogen (infective dose of approximately 100,000 parasites as determined by counting using the Uriglass disposable counting chamber (Menarini Diagnostics, Austria)) was administered by slow intravenous injection into the jugular vein of recipient calves within 15 min after collection. For assessment of trypanocide efficacy in study CV12/885, two groups of six animals each, namely groups A and B (i.e. 12 out of the 45 infected cattle) were infected with the drug resistant strain KONT 2/133 and each group was given a different trypanocide 9 days after infection when obvious parasitaemia and anaemia were present together with variable clinical signs. Day of first treatment administration was designated day 0. Animals were then monitored for 100 days according to Eisler et al. (2001) .
Animals in group B relapsed and were retreated with another trypanocide 19 days after the first treatment. Animals in Group A did not relapse after treatment.
From the infected animals, blood for PCR and parasite detection was collected on either 9 or 5 days pre-infection (45 trypanosome negative control specimens) and at 14 days post-infection and prior to trypanocide administration (45 trypanosome positive control specimens). From the non-infected animals, blood was taken at days corresponding with the sampling from the infected animals (24 trypanosome negative control specimens). These specimens were used for evaluation of the sensitivity and specificity of ITS1 TD PCR.
From groups A and B, blood samples for PCR and HCT were collected after treatment with trypanocides, on 1, 2, 3, 4, 6, 10, 16, 23, 30 and 44 days post-treatment. These specimens were used for evaluation as a "test of cure" of ITS1 TD PCR. Blood was drawn from the jugular vein into K 2 -EDTA vacutainer tubes. The blood was stored at −80 • C for subsequent DNA extraction. For parasite detection, blood was drawn into heparinised collection tubes, transferred to 6 heparin-containing capillary tubes and centrifuged for 6 min at 13,000 × g. The buffy coat was examined under a microscope for the presence of living trypanosomes according to Woo (1970) .
For assessing the specificity of the PCR primers, noninfected blood collected on heparin or on Na 2 -EDTA from bovine, goat, dog, horse, human and mouse was used.
DNA purification
Total genomic DNA was extracted from 200 l of blood using the High Pure PCR Template Purification Kit (Roche Applied Sciences) according to the manufacturer's instructions, except that bound DNA was eluted with 60 l elution buffer instead of 200 l. Purified DNA was stored at −80 • C. Each round of DNA extraction included a negative control (PCR-grade water) and a positive control (parasite DNAspiked blood) alongside the bovine blood specimens. For determination of the analytical sensitivity, trypanosomes were grown in mice and parasites were counted in a Uriglass cell counting chamber. Since bovine blood was not readily available at the ITM in Antwerp, 10-fold serial dilutions of parasites were prepared in 1 ml volumes of ice-cold freshly collected naïve human or mouse blood. Two hundred l of the thus prepared blood series were subjected to DNA purification as described above. For assessment of analytical specificity, trypanosomes were grown in mice. Trypanosomes were separated from the blood by anion exchange chromatography (Lanham and Godfrey, 1970) and subjected to DNA purification with the DNeasy Blood and Tissue kit (Qiagen) according to the manufacturer's instructions. PCR products were resolved by electrophoresis at 6 V/cm in 2% (w/v) agarose gels stained with 0.5 g/ml ethidium bromide, and photographed under ultraviolet light.
ITS1 TD PCR and agarose electrophoresis analysis
Vertebrate cytochrome b PCR
On all blood specimens that were negative in the ITS1 TD PCR, a PCR for vertebrate cytochrome b was performed (Kocher et al., 1989; Fikru et al., 2012) . A positive result with vertebrate cytochrome b PCR indicates that a negative ITS1 TD PCR result of the same specimen is not due to poor DNA quality or presence of inhibitors.
Results
Analytical specificity and sensitivity of ITS1 TD PCR
The ITS1 TD PCR assay conditions were optimised in order to obtain maximal specificity and sensitivity using parasite-infected mouse blood, and non-infected blood from mouse, human, bovine, goat, horse and dog. No cross-reactivity was observed with the non-infected blood specimens, while the ITS1 TD PCR allowed detection and differentiation of the trypanosome taxa by amplicon length polymorphism. Indeed, the assay generated amplicons of the expected sizes: 612 bp with T. congolense Savannah type, 165 bp with T. vivax and 391-393 bp with the Trypanozoon subgenus, including T. b. brucei, T. b. gambiense, T. b. rhodesiense, T. evansi, and T. equiperdum. The nonpathogenic T. theileri could be discriminated by a PCR amplicon of approximately 300 bp (Fig. 1) . To assess the lower detection limit according to the trypanosome taxon, 10-fold serial dilutions of live parasites in 1 ml aliquots of naïve human blood were used. At 200 l blood per sample, ITS1 TD PCR achieved an analytical sensitivity of 10 parasites/ml blood or 0.2 parasite equivalent/reaction with T. congolense (Fig. 2) , T. brucei and T. evansi (data not shown). The analytical sensitivity of ITS1 TD PCR for T. vivax was 100 parasites/ml blood or 2 parasite equivalent/reaction (Fig. 3) . 
Fig. 2.
Ethidium bromide-stained agarose gel electrophoresis of ITS1 TD PCR products of T. congolense Savannah type genomic DNA extracted from blood. 10 5 , 10 4 , 10 3 , 10 2 , 10, 5: 10 5 parasites per ml blood, 10 4 parasites per ml blood, 10 3 parasites per ml blood, 10 2 parasites per ml blood, 10 parasites per ml blood and 5 parasite per ml blood, respectively; naïve: non-infected blood; NC: no-template negative control. M: 100-bp incremental markers. Each reaction contained the equivalent of 20 L of blood.
Performance of ITS1 TD PCR on clinical specimens
A total of 246 blood specimens from 57 cattle were examined with ITS1 TD PCR and HCT and results were interpreted with reference to their infection status with T. congolense Savannah or Kilifi type. Specimens that were negative in ITS1 TD PCR were verified with the vertebrate cytochrome b PCR and were all positive (data not shown).
Firstly, specificity and sensitivity of ITS1 TD PCR were evaluated on a collection of 114 reference specimens (69 non-infected and 45 infected specimens) from 57 cattle of known disease status. Specificity of ITS1 TD PCR was 100%, which was in agreement with that of HCT. Sensitivity of ITS1 TD PCR at 14 days post infection was 100%, and that of HCT was 97.8%. Fig. 3 . Ethidium bromide-stained agarose gel electrophoresis of ITS1 TD PCR products of T. vivax gDNA extracted from blood. 10 5 , 10 4 , 10 3 , 10 2 , 10, 1: 10 5 parasites per ml blood, 10 4 parasites per ml blood, 10 3 parasites per ml blood, 10 2 parasites per ml blood, 10 parasites per ml blood and 1 parasite per ml blood, respectively; naïve: non-infected blood, NC: notemplate negative control. M: 100 bp incremental markers. Each reaction contained the equivalent of 20 L of blood. Secondly, ITS1 TD PCR was evaluated as a test of cure on the collection of 132 post-treatment specimens in 12 cattle (groups A and B) that were treated and followed up. Four out of six animals in group A became negative within 1 day post treatment with both ITS1 TD PCR and HCT (Table 1) . After 1 day of treatment, one animal was positive in ITS1 TD PCR and negative in HCT, and another animal was positive in HCT and negative in ITS1 TD PCR. From 2 days post-treatment till the end of the sampling period (44 days after first treatment), all animals were negative in both the ITS1 TD PCR and the HCT. In group B, all six animals were occasionally positive in ITS1 TD PCR and/or HCT during the follow-up period between 1 and 16 days after treatment and even after retreatment (on day 19) up to day 44 after treatment ( Table 2 ). The parasite detection rate of ITS1 TD PCR after two treatments in animal group B was higher than that of HCT. Positivity rate of ITS1 TD PCR was 84.85% (56/66), while HCT was 57.58% (38/66). The ITS1 TD PCR could detect relapse up to three days earlier than microscopical parasite detection.
Discussion
Livestock production is considered the main lifeline for millions of families in many sub-Saharan countries.
However, the emergence of drug resistant trypanosomes presents a serious threat to agriculture in the regions. Therefore, studies on drug resistance and development of novel compounds against trypanosomes are necessary for effective control. These studies greatly benefit from rapid and cost-efficient molecular tools to detect the presence of trypanosomes. Compared to microscopy, PCR-based assays have the advantage that they are more amenable to high throughput processing and that specimens can be stored longer term. In addition, differentiation between trypanosome taxa by microscopy is much more cumbersome than with molecular methods, such as PCR. This study presents an improved ITS1-based PCR assay for diagnosis of trypanosomosis and for efficacy assessment of trypanocidal compounds where the detection of genomic rDNA of Trypanosoma specific ITS1 serves as surrogate for parasite detection but with higher analytical sensitivity. The same primer sequences were employed in a previous survey on AAT in Ethiopia (Fikru et al., 2012) . However, the reaction mixture and cycling conditions of the ITS1 TD PCR are refined for optimal sensitivity and specificity. The "Touchdown" approach that employs more stringent primer-template hybridisation conditions is introduced to minimise potential non-specific amplifications. It favours amplification of desirable products during early cycles that will out-compete potential non-specific products during the remaining cycles (Korbie and Mattick, 2008) . For T. congolense, the newly developed ITS1 TD PCR has a lower detection limit of 10 parasites/ml blood while for T. vivax, this is 100 parasites/ml blood. A similar difference in detection limits between T. congolense and T. vivax has been observed in other PCRs such as the original ITS1 PCR and a real-time PCR targeting the 18S rDNA sequence (unpublished results) and might be due to a lower copy number of target sequences in the T. vivax genome compared to T. congolense. Currently, the 18S based PCR-RFLP is the FAO recommended test for detection and differentiation of multiple trypanosome taxa (Geysen et al., 2003) . The 18S PCR-RFLP requires one or two amplification steps and a restriction digestion step. On the other hand, the ITS1 TD PCR needs a single amplification step and achieves a comparable detection limit, is thus less-time consuming and more cost-effective for detection of T. congolense, T. vivax and the three species within the Trypanozoon subgenus T. brucei, T. evansi and T. equiperdum.
The data obtained with the blood specimens of experimentally infected cattle demonstrated that ITS1 TD PCR had comparable performance to microscopy in revealing the absence or presence of a T. congolense infection prior to treatment. After curative treatment, the ITS1 TD PCR became negative in all animals within no more than two days, thus proving the rapid clearance of DNA from dead parasites in the blood. The discordant result at day 1 post-treatment in animal CVB 190, with positive HCT and negative ITS1 TD PCR was confirmed with a negative result in the 18S-based real-time PCR developed in our laboratory (unpublished), but cannot be explained. In the animals that relapsed after treatment, ITS1 TD PCR achieved a higher positivity rate and was able to detect recrudescence of parasitaemia several days earlier than HCT. Therefore, ITS1 TD PCR can be considered more reliable than microscopy in assessment of trypanocide efficacy and bears the potential to allow shortening of the post-treatment follow-up that is currently recommended to be 100 days.
In summary, the ITS1 TD PCR offers an alternative tool for trypanosome diagnosis and assessment of compound efficacy against T. congolense in cattle. The ability to detect and differentiate multiple Trypanosoma taxa in a single run, with the potential to identify mixed infections, indicates the application of the ITS1 TD PCR for research on other pathogenic trypanosomes, such as T. vivax, T. evansi, T. equiperdum and T. brucei.
